Use of HIFU for Tremor-Dominant Parkinson’s Disease: A Patient Success Story - Report - MDSpire

Use of HIFU for Tremor-Dominant Parkinson’s Disease: A Patient Success Story

  • By

  • April 17, 2026

  • 7 min

Share

Clinical Report: Use of HIFU for Tremor-Dominant Parkinson’s Disease

Overview

This report discusses the successful application of High-Intensity Focused Ultrasound (HIFU) in treating tremor-dominant Parkinson's disease in a patient who experienced debilitating tremors. The non-invasive nature of HIFU provided significant symptom relief, marking a promising alternative to traditional invasive treatments.

Background

Tremor-dominant Parkinson's disease is a distinct subset of Parkinson's where tremors are the primary symptom, significantly impacting patients' quality of life. Traditional treatments, including medications and invasive procedures like Deep Brain Stimulation (DBS), may not always provide adequate relief. HIFU represents a novel, non-invasive approach that targets the thalamus to alleviate tremors, offering hope for patients who are refractory to conventional therapies.

Data Highlights

No numerical data was provided in the article.

Key Findings

  • Mr. Sick was diagnosed with tremor-dominant Parkinson's disease after extensive consultations.
  • Traditional medications failed to alleviate his tremors, leading to significant lifestyle changes.
  • HIFU is an FDA-approved, non-invasive treatment that targets the thalamus to reduce tremors.
  • Mr. Sick experienced immediate symptom relief following the HIFU procedure.
  • HIFU offers a less invasive alternative to Deep Brain Stimulation for managing tremors.

Clinical Implications

The case highlights the potential of HIFU as a viable treatment option for patients with tremor-dominant Parkinson's disease who do not respond to medications. Clinicians should consider HIFU as part of a multidisciplinary approach to managing tremors in this patient population.

Conclusion

HIFU represents a significant advancement in the treatment of tremor-dominant Parkinson's disease, providing a non-invasive option that can lead to substantial improvements in patient quality of life. Further studies are warranted to establish long-term efficacy and safety.

References

  1. UCI Health, UCI Health News, 2023 -- First UCI Health patient treated for essential tremor with incision-free MR-guided focused ultrasound
  2. UCI Health, UCI Health News, 2023 -- Incision-free, outpatient therapy for essential tremor and tremor-predominant Parkinson’s
  3. Springer, 2023 -- Assessing the Learning Curve and Impact of Operator Experience on Procedural and Clinical Outcomes in MRgFUS Thalamotomy for Tremor Management
  4. JAMA Network, 2017 -- Safety and Efficacy of Focused Ultrasound Thalamotomy for Patients With Medication-Refractory, Tremor-Dominant Parkinson Disease: A Randomized Clinical Trial
  5. Modulating the Subthalamic Nucleus in Parkinson's Disease: Impact of Fiber Tract Stimulation on Tremor Management
  6. SUMMARY OF SAFETY AND EFFECTIVENESS DATA (SSED)
  7. Safety and Efficacy of Focused Ultrasound Thalamotomy for Patients With Medication-Refractory, Tremor-Dominant Parkinson Disease: A Randomized Clinical Trial | Neurosurgery | JAMA Neurology | JAMA Network

Original Source(s)

Related Content